Standout Papers

CellMarker 2.0: an update... 2022 2026 2023 2024 2022 100 200 300 400

Immediate Impact

1 by Nobel laureates 1 from Science/Nature 71 hit
Sub-graph 1 of 24

Citing Papers

Rational Design of Nanozymes for Engineered Cascade Catalytic Cancer Therapy
2025 Hit
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
2025 Hit
1 intermediate paper

Works of Yingqi Xu being referenced

CellMarker 2.0: an updated database of manually curated cell markers in human/mouse and web tools based on scRNA-seq data
2022 Hit
Nanoparticle-mediated inhibition of survivin to overcome drug resistance in cancer therapy
2016

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yingqi Xu 939 581 449 377 213 78 2.2k
Weijun Qin 875 0.9× 306 0.5× 478 1.1× 135 0.4× 226 1.1× 97 2.2k
Youjie Li 870 0.9× 140 0.2× 611 1.4× 224 0.6× 117 0.5× 114 1.9k
Yi‐Hsuan Hsiao 546 0.6× 320 0.6× 264 0.6× 718 1.9× 77 0.4× 120 2.8k
Yingwei Chen 1.4k 1.5× 187 0.3× 279 0.6× 215 0.6× 421 2.0× 125 3.2k
Byung-Chul Kim 1.2k 1.3× 115 0.2× 251 0.6× 247 0.7× 194 0.9× 121 2.8k
Yühong Huang 1.2k 1.2× 169 0.3× 195 0.4× 360 1.0× 112 0.5× 152 2.7k
Ping Li 783 0.8× 361 0.6× 578 1.3× 78 0.2× 152 0.7× 101 2.2k
Lingfeng Chen 1.3k 1.4× 96 0.2× 305 0.7× 216 0.6× 352 1.7× 129 3.2k
Zhigang Wang 797 0.8× 134 0.2× 305 0.7× 141 0.4× 99 0.5× 89 1.7k
Luca Crippa 531 0.6× 261 0.4× 82 0.2× 228 0.6× 63 0.3× 83 1.9k

All Works

Loading papers...

Rankless by CCL
2026